Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• Auteurs principaux: Xiao-yi Bao (Auteur), Qun Zheng (Auteur), Qiang Tong (Auteur), Peng-chong Zhu (Auteur), Zhuang Zhuang (Auteur), Guo-qing Zheng (Auteur), Yan Wang (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...